Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2024

Open Access 01-12-2024 | Arterial Diseases | Research

Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis

Authors: Sarah Silva, Segun Fatumo, Dorothea Nitsch

Published in: Systematic Reviews | Issue 1/2024

Login to get access

Abstract

Background

Coronary artery disease (CAD) remains one of the leading causes of mortality worldwide. We aimed to summarize what is currently known with regard to causal modifiable risk factors associated with CAD in populations of diverse ancestries through conducting a systematic review and meta-analysis of Mendelian randomization (MR) studies on CAD.

Methods

The databases Embase, Medline, Cochrane Library and Web of Science were searched on the 19th and 20th of December 2022 for MR studies with CAD as a primary outcome; keywords of the search strategy included “coronary artery disease” and “mendelian randomization”. Studies were included if they were published in the English language, included only human participants, employed Mendelian randomization as the primary methodology and studied CAD as the outcome of interest. The exclusion criteria resulted in the removal of studies that did not align with the predefined inclusion criteria, as well as studies which were systematic reviews themselves, and used the same exposure and outcome source as another study.
An ancestry-specific meta-analysis was subsequently conducted on studies which investigated either body mass index, lipid traits, blood pressure or type 2 diabetes as an exposure variable. Assessment of publication bias and sensitivity analyses was conducted for risk of bias assessment in the included studies.

Results

A total of 1781 studies were identified through the database searches after de-duplication was performed, with 47 studies included in the quantitative synthesis after eligibility screening. Approximately 80% of all included study participants for MR studies on CAD were of European descent irrespective of the exposure of interest, while no study included individuals of African ancestry. We found no evidence of differences in terms of direction of causation between ancestry groups; however, the strength of the respective relationships between each exposure and CAD were different, with this finding most evident when blood pressure was the exposure of interest.

Conclusions

Findings from this review suggest that patterns regarding the causational relationship between modifiable risk factors and CAD do not differ in terms of direction when compared across diverse ancestry populations. Differences in the observed strengths of the respective relationships however are indicative of the value of increasing representation in non-European populations, as novel genetic pathways or functional SNPs relating to CAD may be uncovered through a more global analysis.

Systematic review registration

The protocol for this systematic review was registered to the International Prospective Register of Systematic Reviews (PROSPERO) and is publicly available online (CRD42021272726).
Appendix
Available only for authorised users
Literature
1.
2.
Aragam KG, Jiang T, Goel A, Kanoni S, Wolford BN, Atri DS, Weeks EM, Wang M, Hindy G, Zhou W, Grace C. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat Genet. 2022;54(12):1803–15.PubMedPubMedCentralCrossRef
3.
Wang Z, Kang C, Xu P, Zhang S, Song JH, Wang D, Yuan S, Lee HJ, Zhang M, Wang Z, Sun H. Osteoarthritis and cardiovascular disease: a Mendelian randomization study. Front Cardiovasc Med. 2022;18(9):1025063.CrossRef
4.
Ke W, Rand KA, Conti DV, Setiawan VW, Stram DO, Wilkens L, Le Marchand L, Assimes TL, Haiman CA. Evaluation of 71 coronary artery disease risk variants in a multiethnic cohort. Front Cardiovasc Med. 2018;14(5):19.CrossRef
5.
Chen Z, Schunkert H. Genetics of coronary artery disease in the post-GWAS era. J Intern Med. 2021;290(5):980–92.PubMedCrossRef
6.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 2020;395(10226):795–808.CrossRef
7.
Abbasi SH, Sundin Ö, Jalali A, Soares J, Macassa G. Ethnic differences in the risk factors and severity of coronary artery disease: a patient-based study in Iran. J Racial Ethn Health Disparities. 2018;5:623–31.PubMedCrossRef
8.
9.
10.
Bondemark L, Ruf S. Randomized controlled trial: the gold standard or an unobtainable fallacy? Eur J Orthod. 2015;37(5):457–61.PubMedCrossRef
11.
Mutie PM, Pomares-Milan H, Atabaki-Pasdar N, Coral D, Fitipaldi H, Tsereteli N, Tajes JF, Franks PW, Giordano GN. Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women. Diabetologia. 2023;66(2):321–35.PubMedCrossRef
12.
Lee SH, Lee JY, hui Kim G, Jung KJ, Lee S, Kim HC, Jee SH. Two-sample Mendelian randomization study of lipid levels and ischemic heart disease. Korean Circ J. 2020;50(10):940–8.PubMedPubMedCentralCrossRef
13.
White J, Sofat R, Hemani G, Shah T, Engmann J, Dale C, Shah S, Kruger FA, Giambartolomei C, Swerdlow DI, Palmer T. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2016;4(4):327–36.PubMedPubMedCentralCrossRef
14.
Larsson SC, Burgess S, Mason AM, Michaëlsson K. Alcohol consumption and cardiovascular disease: a Mendelian randomization study. Circ Genom Precis Med. 2020;13(3):e002814.PubMedPubMedCentralCrossRef
15.
Si S, Tewara MA, Li Y, Li W, Chen X, Yuan T, Liu C, Li J, Wang B, Li H, Hou L. Causal pathways from body components and regional fat to extensive metabolic phenotypes: a Mendelian randomization study. Obesity. 2020;28(8):1536–49.PubMedCrossRef
16.
Ross S, Gerstein HC, Eikelboom J, Anand SS, Yusuf S, Paré G. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease. Eur Heart J. 2015;36(23):1454–62.PubMedCrossRef
17.
Liu B, Mason AM, Sun L, Di Angelantonio E, Gill D, Burgess S. Genetically predicted type 2 diabetes mellitus liability, glycated hemoglobin and cardiovascular diseases: a wide-angled Mendelian randomization study. Genes. 2021;12(10):1644.PubMedPubMedCentralCrossRef
18.
Zhang Q, Liu HM, Lv WQ, He JY, Xia X, Zhang WD, Deng HW, Sun CQ. Additional common variants associated with type 2 diabetes and coronary artery disease detected using a pleiotropic cFDR method. J Diabetes Complications. 2018;32(12):1105–12.PubMedPubMedCentralCrossRef
19.
Lyall DM, Celis-Morales C, Ward J, Iliodromiti S, Anderson JJ, Gill JM, Smith DJ, Ntuk UE, Mackay DF, Holmes MV, Sattar N. Association of body mass index with cardiometabolic disease in the UK Biobank: a Mendelian randomization study. JAMA cardiology. 2017;2(8):882–9.PubMedPubMedCentralCrossRef
20.
Thomas DG, Wei Y, Tall AR. Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study. J Lipid Res. 2021;1:62.
21.
22.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):1–9.
23.
Skrivankova VW, Richmond RC, Woolf BA, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JP, Dimou N, Langenberg C, Loder EW. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233.PubMedPubMedCentralCrossRef
24.
25.
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. BMJ Ment Health. 2019;22(4):153–60.
26.
Ahmad OS, Morris JA, Mujammami M, Forgetta V, Leong A, Li R, Turgeon M, Greenwood CM, Thanassoulis G, Meigs JB, Sladek R. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun. 2015;6(1):7060.PubMedCrossRef
27.
Allara E, Morani G, Carter P, Gkatzionis A, Zuber V, Foley CN, Rees JM, Mason AM, Bell S, Gill D, Lindström S. Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled Mendelian randomization investigation. Circ Genom Precis Med. 2019;12(12):e002711.PubMedPubMedCentralCrossRef
28.
Cole CB, Nikpay M, Stewart AF, McPherson R. Increased genetic risk for obesity in premature coronary artery disease. Eur J Hum Genet. 2016;24(4):587–91.PubMedCrossRef
29.
Dale CE, Fatemifar G, Palmer TM, White J, Prieto-Merino D, Zabaneh D, Engmann JE, Shah T, Wong A, Warren HR, McLachlan S. Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation. 2017;135(24):2373–88.PubMedPubMedCentralCrossRef
30.
Fang X, Zuo J, Zhou J, Cai J, Chen C, Xiang E, Li H, Cheng X, Chen P. Childhood obesity leads to adult type 2 diabetes and coronary artery diseases: a 2-sample Mendelian randomization study. Medicine. 2019;98(32):e16825.PubMedPubMedCentralCrossRef
31.
Gan W, Bragg F, Walters RG, Millwood IY, Lin K, Chen Y, Guo Y, Vaucher J, Bian Z, Bennett D, Lv J. Genetic predisposition to type 2 diabetes and risk of subclinical atherosclerosis and cardiovascular diseases among 160,000 Chinese adults. Diabetes. 2019;68(11):2155–64.PubMedPubMedCentralCrossRef
32.
Geng T, Smith CE, Li C, Huang T. Childhood BMI and adult type 2 diabetes, coronary artery diseases, chronic kidney disease, and cardiometabolic traits: a Mendelian randomization analysis. Diabetes Care. 2018;41(5):1089–96.PubMedCrossRef
33.
Gill D, Zuber V, Dawson J, Pearson-Stuttard J, Carter AR, Sanderson E, Karhunen V, Levin MG, Wootton RE, Klarin D, Tsao PS. Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis. Int J Obes. 2021;45(7):1428–38.CrossRef
34.
Gordillo-Marañón M, Zwierzyna M, Charoen P, Drenos F, Chopade S, Shah T, Engmann J, Chaturvedi N, Papacosta O, Wannamethee G, Wong A. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. Nat Commun. 2021;12(1):6120.PubMedPubMedCentralCrossRef
35.
Grace C, Hopewell JC, Watkins H, Farrall M, Goel A. Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes. Genet Epidemiol. 2022;46(1):51–62.PubMedCrossRef
36.
Haase CL, Tybjærg-Hansen A, Ali Qayyum A, Schou J, Nordestgaard BG, Frikke-Schmidt R. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocrinol Metab. 2012;97(2):E248–56.PubMedCrossRef
37.
Hägg S, Fall T, Ploner A, Mägi R, Fischer K, Draisma HH, Kals M, de Vries PS, Dehghan A, Willems SM, Sarin AP. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol. 2015;44(2):578–86.PubMedPubMedCentralCrossRef
38.
Helgadottir A, Thorleifsson G, Snaebjarnarson A, Stefansdottir L, Sveinbjornsson G, Tragante V, Björnsson E, Steinthorsdottir V, Gretarsdottir S, Helgason H, Saemundsdottir J. Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis. Eur J Prev Cardiol. 2022;29(18):2374–85.PubMedCrossRef
39.
Holmes MV, Lange LA, Palmer T, Lanktree MB, North KE, Almoguera B, Buxbaum S, Chandrupatla HR, Elbers CC, Guo Y, Hoogeveen RC. Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet. 2014;94(2):198–208.PubMedPubMedCentralCrossRef
40.
Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, Tragante V. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015;36(9):539–50.PubMedCrossRef
41.
Hu X, Zhuang XD, Mei WY, Liu G, Du ZM, Liao XX, Li Y. Exploring the causal pathway from body mass index to coronary heart disease: a network Mendelian randomization study. Ther Adv Chronic Dis. 2020;11:2040622320909040.PubMedPubMedCentralCrossRef
42.
Huang M, Laina-Nicaise LD, Zha L, Tang T, Cheng X. Causal association of type 2 diabetes Mellitus and glycemic traits with cardiovascular diseases and lipid traits: a Mendelian randomization study. Front Endocrinol. 2022;13:840579.CrossRef
43.
Huang QQ, Sallah N, Dunca D, Trivedi B, Hunt KA, Hodgson S, Lambert SA, Arciero E, Wright J, Griffiths C, Trembath RC. Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals. Nat Commun. 2022;13(1):4664.PubMedPubMedCentralCrossRef
44.
Jansen SA, Huiskens B, Trompet S, Jukema J, Mooijaart SP, van Willems Dijk K, van Heemst D, Noordam R. Classical risk factors for primary coronary artery disease from an aging perspective through Mendelian randomization. Geroscience. 2022;44(3):1703–13.PubMedCrossRef
45.
Jia Y, Wang R, Guo D, Sun L, Shi M, Zhang K, Yang P, Zang Y, Wang Y, Liu F, Zhang Y. Contribution of metabolic risk factors and lifestyle behaviors to cardiovascular disease: a Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2022;32(8):1972–81.PubMedCrossRef
46.
Larsson SC, Bäck M, Rees JM, Mason AM, Burgess S. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J. 2020;41(2):221–6.PubMedCrossRef
47.
Le NN, Tran TQ, Lip S, McCallum L, McClure J, Dominiczak AF, Gill D, Padmanabhan S. Unravelling the distinct effects of systolic and diastolic blood pressure using Mendelian randomisation. Genes. 2022;13(7):1226.PubMedPubMedCentralCrossRef
48.
Leyden GM, Shapland CY, Smith GD, Sanderson E, Greenwood MP, Murphy D, Richardson TG. Harnessing tissue-specific genetic variation to dissect putative causal pathways between body mass index and cardiometabolic phenotypes. Am J Hum Genet. 2022;109(2):240–52.PubMedPubMedCentralCrossRef
49.
Lv WQ, Zhang X, Fan K, Xia X, Zhang Q, Liu HM, Jiang BY, Zhang WD, Deng HW. Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits. Eur J Hum Genet. 2018;26(10):1547–53.PubMedPubMedCentralCrossRef
50.
Malik R, Georgakis MK, Vujkovic M, Damrauer SM, Elliott P, Karhunen V, Giontella A, Fava C, Hellwege JN, Shuey MM, Edwards TL. Relationship between blood pressure and incident cardiovascular disease: linear and nonlinear Mendelian randomization analyses. Hypertension. 2021;77(6):2004–13.PubMedCrossRef
51.
Merino J, Leong A, Posner DC, Porneala B, Masana L, Dupuis J, Florez JC. Genetically driven hyperglycemia increases risk of coronary artery disease separately from type 2 diabetes. Diabetes Care. 2017;40(5):687–93.PubMedPubMedCentralCrossRef
52.
Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg-Hansen A, Davey Smith G, Timpson NJ. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med. 2012;9(5):e1001212.PubMedPubMedCentralCrossRef
53.
Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med. 2020;17(3):e1003062.PubMedPubMedCentralCrossRef
54.
Si S, Hou L, Chen X, Li W, Liu X, Liu C, Li Y, Yuan T, Li J, Wang B, Li H. Exploring the causal roles of circulating remnant lipid profile on cardiovascular and cerebrovascular diseases: Mendelian randomization study. J Epidemiol. 2022;32(5):205–14.PubMedPubMedCentralCrossRef
55.
Tragante V, Asselbergs FW, Swerdlow DI, Palmer TM, Moore JH, de Bakker PI, Keating BJ, Holmes MV. Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk. Hum Genet. 2016;135(5):453–67.PubMedPubMedCentralCrossRef
56.
Trinder M, Zekavat SM, Uddin MM, Pampana A, Natarajan P. Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein (a). Cardiovasc Res. 2021;117(5):1245–7.PubMedPubMedCentralCrossRef
57.
Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427–36.PubMedCrossRef
58.
Verkouter I, de Mutsert R, Smit RA, Trompet S, Rosendaal FR, van Heemst D, van Willems Dijk K, Noordam R. The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study. Int J Epidemiol. 2020;49(4):1246–56.PubMedPubMedCentralCrossRef
59.
Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, Schunkert H. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. The Lancet. 2012;380(9841):572–80.CrossRef
60.
Wan EY, Fung WT, Schooling CM, Au Yeung SL, Kwok MK, Yu EY, Wang Y, Chan EW, Wong IC, Lam CL. Blood pressure and risk of cardiovascular disease in UK biobank: a Mendelian randomization study. Hypertension. 2021;77(2):367–75.PubMedCrossRef
61.
Wang K, Shi X, Zhu Z, Hao X, Chen L, Cheng S, Foo RS, Wang C. Mendelian randomization analysis of 37 clinical factors and coronary artery disease in East Asian and European populations. Genome medicine. 2022;14(1):1–5.CrossRef
62.
White J, Swerdlow DI, Preiss D, Fairhurst-Hunter Z, Keating BJ, Asselbergs FW, Sattar N, Humphries SE, Hingorani AD, Holmes MV. Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiol. 2016;1(6):692–9.PubMedPubMedCentralCrossRef
63.
Xu L, Borges MC, Hemani G, Lawlor DA. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study. Diabetologia. 2017;60(11):2210–20.PubMedPubMedCentralCrossRef
64.
Zhang X, Lv WQ, Qiu B, Zhang LJ, Qin J, Tang FJ, Wang HT, Li HJ, Hao YR. Assessing causal estimates of the association of obesity-related traits with coronary artery disease using a Mendelian randomization approach. Sci Rep. 2018;8(1):7146.PubMedPubMedCentralCrossRef
65.
Lu X, Huang J, Wang L, Chen S, Yang X, Li J, Cao J, Chen J, Li Y, Zhao L, Li H. Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese. Hypertension. 2015;66(4):786–92.PubMedCrossRef
66.
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.PubMedCrossRef
67.
Peterson RE, Kuchenbaecker K, Walters RK, Chen CY, Popejoy AB, Periyasamy S, Lam M, Iyegbe C, Strawbridge RJ, Brick L, Carey CE. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell. 2019;179(3):589–603.PubMedPubMedCentralCrossRef
68.
Cheema AN, Pirim D, Wang X, Ali J, Bhatti A, John P, Feingold E, Demirci FY, Kamboh MI. Association study of coronary artery disease-associated genome-wide significant SNPs with coronary stenosis in Pakistani population. Dis Markers. 2020;27:2020.
69.
Tan ST, Scott W, Panoulas V, Sehmi J, Zhang W, Scott J, Elliott P, Chambers J, Kooner JS. Coronary heart disease in Indian Asians. Glob Cardiol Sci Pract. 2014;2014(1):4.CrossRef
70.
Gijsberts CM, Groenewegen KA, Hoefer IE, Eijkemans MJ, Asselbergs FW, Anderson TJ, Britton AR, Dekker JM, Engström G, Evans GW, de Graaf J. Race/ethnic differences in the associations of the Framingham risk factors with carotid IMT and cardiovascular events. PLoS ONE. 2015;10(7):e0132321.PubMedPubMedCentralCrossRef
71.
Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, Röther J, Goto S, Liau CS, Wilson PW, Salette G, Smith SC, Steg PG. Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Mayo Clinic Proceedings. Elsevier. 2011;86(10):960–7.
72.
Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297(3):286–94.PubMedCrossRef
73.
Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). The lancet. 2000;356(9226):279–84.CrossRef
Metadata
Title
Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis
Authors
Sarah Silva
Segun Fatumo
Dorothea Nitsch
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2024
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-023-02442-8

Other articles of this Issue 1/2024

Systematic Reviews 1/2024 Go to the issue

Research

Comparative analysis of Cochrane and non-Cochrane reviews over three decades

Protocol

Mechanisms behind gender transformative approaches targeting adolescent pregnancy in low- and middle-income countries: a realist synthesis protocol

Protocol

Connected speech features in non-English speakers with Alzheimer’s disease: protocol for scoping review

Protocol

Understanding how therapeutic exercise prescription changes outcomes important to patients with persistent non-specific low back pain: a realist review protocol

Research

Does arthroscopic or open washout in native knee septic arthritis result in superior post-operative function? A systematic review and meta-analysis of randomised controlled trials and observational studies

Research

Reported outcomes in patients with iron deficiency or iron deficiency anemia undergoing major surgery: a systematic review of outcomes